Detection of human papillomavirus by the polymerase chain reaction
Patent 5527898 Issued on June 18, 1996. Estimated Expiration Date: 
June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesHuman papillomavirus 35 nucleic acid hybridization probes and methods for employing the same Human papillomavirus 56 nucleic acid hybridization probes and methods for employing the same Type-specific papillomavirus DNA sequences and peptides Human papilloma virus type 57 and the DNA thereof Patent #: 5187090 Inventors
AssigneeApplicationNo. 474542 filed on 06/07/1995US Classes:536/24.3, Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNA435/5, Involving virus or bacteriophage435/6, Involving nucleic acid435/91.1, Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.)435/91.2, Acellular exponential or geometric amplification (e.g., PCR, etc.)436/501, BIOSPECIFIC LIGAND BINDING ASSAY536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)536/24.1, Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.)536/24.31, Probes for detection of animal nucleotide sequences536/24.32, Probes for detection of microbial nucleotide sequences536/24.33PrimersExaminersPrimary: Jones, W. GaryAssistant: Marschel, Ardin H. Attorney, Agent or FirmForeign Patent References
International ClassesC07H 021/04C12Q 001/68 AbstractThe presence of human papillomavirus (HPV) in a sample can be detected and the HPV typed by a method that involves the amplification of HPV DNA sequences by the polymerase chain reaction (PCR). The primers used in the method are consensus primers that can be used to amplify a particular region of the genome of any HPV. The presence of HPV in a sample is indicated by the formation of amplified DNA. The HPV nucleic acid is detected by consensus probes that may be short oligonucleotide probes or long generic probes. The HPV is typed by the use of type-specific DNA probes specific for the amplified region of DNA.Other References
Field of SearchInvolving virus or bacteriophageInvolving nucleic acid Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) Acellular exponential or geometric amplification (e.g., PCR, etc.) BIOSPECIFIC LIGAND BINDING ASSAY N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) DNA or RNA fragments or modified forms thereof (e.g., genes, etc.) Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.) |
| ||||||||||||||
